Literature DB >> 15999920

Utilisation of macrolides and the development of Streptococcus pyogenes resistance to erythromycin.

Karel Urbánek1, Milan Kolár, Luboslava Cekanová.   

Abstract

OBJECTIVES: The aim of the study was to evaluate the relationship between the development of the resistance of Streptococcus pyogenes strains to erythromycin and the utilisation of macrolides in the Olomouc region, Czech Republic.
METHOD: During the period 1997-2001, data for utilisation of macrolides was obtained from the database of the regional General Health Insurance Company and expressed indefined daily doses per 1,000 patients per day. S. pyogenes strains were isolated from community patients suffering from acute bacterial tonsillitis. Their susceptibility to antibiotics was assessed by the disk diffusion method.
RESULTS: Utilisation of macrolides increased by 13% in the period 1997-2001; their utilisation represented 11.40% of total antibiotic prescription in 1997 and 15.48% in 2001. Occurrence of erythromycin-resistant S. pyogenes strains increased significantly from 14% in 1997 to 32% in the year 2001 (P < 0.01). In 2000, macrolides consumption decreased non-significantly, but with no concomitant decrease in erythromycin-resistant S. pyogenes strains occurrence. Absolute susceptibility of S. pyogenes, the most important bacterial pathogen in community-acquired bacterial tonsillitis, to penicillin contrasts with increasing macrolide resistance.
CONCLUSIONS: The study documents the influence of increased utilisation of macrolides on bacterial resistance. Penicillin should be a first-choice antibiotic in acute bacterial tornsillitis; macrolides should only be reserved for patients allergic to penicillins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15999920     DOI: 10.1007/s11096-004-6607-0

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  17 in total

1.  Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains.

Authors:  E Giovanetti; M P Montanari; M Mingoia; P E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Variation in antibiotic use in the European Union.

Authors:  O Cars; S Mölstad; A Melander
Journal:  Lancet       Date:  2001-06-09       Impact factor: 79.321

3.  Resistance to erythromycin in group A streptococci.

Authors:  H Seppälä; A Nissinen; H Järvinen; S Huovinen; T Henriksson; E Herva; S E Holm; M Jahkola; M L Katila; T Klaukka
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

4.  Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance.

Authors:  J Kataja; P Huovinen; M Skurnik; H Seppälä
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

5.  The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance.

Authors:  H Seppälä; T Klaukka; J Vuopio-Varkila; A Muotiala; H Helenius; K Lager; P Huovinen
Journal:  N Engl J Med       Date:  1997-08-14       Impact factor: 91.245

6.  Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997).

Authors:  J J Granizo; L Aguilar; J Casal; R Dal-Ré; F Baquero
Journal:  J Antimicrob Chemother       Date:  2000-12       Impact factor: 5.790

7.  Outbreaks of infections with erythromycin-resistant group A streptococci in child day care centres.

Authors:  L Holmström; B Nyman; M Rosengren; S Wallander; T Ripa
Journal:  Scand J Infect Dis       Date:  1990

8.  Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland.

Authors:  H Seppälä; A Nissinen; Q Yu; P Huovinen
Journal:  J Antimicrob Chemother       Date:  1993-12       Impact factor: 5.790

9.  Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain.

Authors:  E Perez-Trallero; M Urbieta; M Montes; I Ayestaran; J M Marimon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-01       Impact factor: 3.267

Review 10.  Antibiotic resistance in group A streptococci.

Authors:  M A Gerber
Journal:  Pediatr Clin North Am       Date:  1995-06       Impact factor: 3.278

View more
  1 in total

1.  Implementation of Antibiotic Stewardship in a University Hospital Setting.

Authors:  Milan Kolar; Miroslava Htoutou Sedlakova; Karel Urbanek; Patrik Mlynarcik; Magdalena Roderova; Kristyna Hricova; Kristyna Mezerova; Pavla Kucova; Jana Zapletalova; Katerina Fiserova; Pavel Kurfurst
Journal:  Antibiotics (Basel)       Date:  2021-01-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.